LncRP11-675F6.3 responds to rapamycin treatment and reduces triglyceride accumulation via interacting with HK1 in hepatocytes by regulating autophagy and VLDL-related proteins.

Lingling Wang, Xiaojuan Fang, Ziyou Yang, Xueling Li, Mengdi Cheng, Liang Cheng, Ganglin Wang, Wei Li, Lin Liu
Author Information
  1. Lingling Wang: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  2. Xiaojuan Fang: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  3. Ziyou Yang: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  4. Xueling Li: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  5. Mengdi Cheng: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  6. Liang Cheng: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  7. Ganglin Wang: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  8. Wei Li: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  9. Lin Liu: Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.

Abstract

Long noncoding RNAs (lncRNAs) have been widely proven to be involved in liver lipid homeostasis. Herein, we identify an upregulated lncRNA named in response to rapamycin treatment using a microarray in HepG2 cells. Knockdown of . leads to a significant reduction in apolipoprotein 100 (ApoB100), microsomal triglyceride transfer protein (MTTP), ApoE and ApoC3 with increased cellular triglyceride level and autophagy. Furthermore, we find that ApoB100 is obviously colocalized with GFP-LC3 in autophagosomes when . is knocked down, indicating that elevated triglyceride accumulation likely related to autophagy induces the degradation of ApoB100 and impairs very low-density lipoprotein (VLDL) assembly. We then identify and validate that hexokinase 1 (HK1) acts as the binding protein of and mediates triglyceride regulation and cell autophagy. More importantly, we find that and HK1 attenuate high fat diet induced nonalcoholic fatty liver disease (NAFLD) by regulating VLDL-related proteins and autophagy. In conclusion, this study reveals that is potentially involved in the downstream of mTOR signaling pathway and the regulatory network of hepatic triglyceride metabolism in cooperation with its interacting protein HK1, which may provide a new target for fatty liver disorder treatment.

Keywords

References

  1. Diabetologia. 2016 Jun;59(6):1098-103 [PMID: 27048250]
  2. Cell. 2012 Apr 13;149(2):274-93 [PMID: 22500797]
  3. JHEP Rep. 2022 Mar 26;4(6):100479 [PMID: 35469167]
  4. Cell Metab. 2015 Mar 3;21(3):455-67 [PMID: 25738460]
  5. Circ Res. 2018 Feb 16;122(4):568-582 [PMID: 29301854]
  6. Hepatology. 2018 May;67(5):1768-1783 [PMID: 29140550]
  7. Int J Mol Sci. 2016 May 17;17(5): [PMID: 27196897]
  8. Circulation. 2001 Feb 20;103(7):926-33 [PMID: 11181465]
  9. Front Genet. 2019 Apr 02;10:281 [PMID: 31001323]
  10. Bio Protoc. 2016 Dec 20;6(24): [PMID: 28516119]
  11. Cell. 2008 Sep 19;134(6):903-5 [PMID: 18805080]
  12. Compr Physiol. 2017 Dec 12;8(1):1-8 [PMID: 29357123]
  13. Nat Rev Endocrinol. 2021 Aug;17(8):484-495 [PMID: 34131333]
  14. Nucleic Acids Res. 2016 Jul 27;44(13):6423-33 [PMID: 27131369]
  15. Mol Cell. 2011 Sep 16;43(6):904-14 [PMID: 21925379]
  16. Acta Biochim Biophys Sin (Shanghai). 2022 Nov 25;54(11):1619-1629 [PMID: 36604144]
  17. Hepatology. 2016 Jul;64(1):73-84 [PMID: 26707365]
  18. Hepatol Commun. 2020 Jan 14;4(4):478-492 [PMID: 32258944]
  19. Nat Protoc. 2006;1(1):241-5 [PMID: 17406239]
  20. Nature. 2016 May 11;534(7605):124-8 [PMID: 27251289]
  21. J Cell Mol Med. 2018 Dec;22(12):5768-5775 [PMID: 30188595]
  22. BMC Bioinformatics. 2018 Dec 19;19(1):533 [PMID: 30567492]
  23. J Hematol Oncol. 2018 Jun 4;11(1):77 [PMID: 29866190]
  24. Structure. 1998 Jan 15;6(1):39-50 [PMID: 9493266]
  25. Nature. 2017 Mar 9;543(7644):199-204 [PMID: 28241135]
  26. Nat Commun. 2018 Jul 30;9(1):2986 [PMID: 30061575]
  27. Curr Opin Lipidol. 2018 Jun;29(3):224-232 [PMID: 29553997]
  28. Cell Rep. 2014 Jan 16;6(1):222-30 [PMID: 24388749]
  29. Methods Mol Biol. 2015;1262:3-19 [PMID: 25555572]

MeSH Term

Humans
Apolipoprotein B-100
Autophagy
Hepatocytes
Hexokinase
LDL-Receptor Related Proteins
Liver
Non-alcoholic Fatty Liver Disease
Triglycerides
RNA, Long Noncoding

Chemicals

Apolipoprotein B-100
Hexokinase
LDL-Receptor Related Proteins
Triglycerides
RNA, Long Noncoding

Word Cloud

Created with Highcharts 10.0.0triglycerideautophagyliverHK1treatmentApoB100proteinfattyinvolvedidentifyrapamycinfindaccumulationlipoproteinhexokinase1nonalcoholicdiseaseregulatingVLDL-relatedproteinsinteracting3LongnoncodingRNAslncRNAswidelyprovenlipidhomeostasisHereinupregulatedlncRNAnamedresponseusingmicroarrayHepG2cellsKnockdownleadssignificantreductionapolipoprotein100microsomaltransferMTTPApoEApoC3increasedcellularlevelFurthermoreobviouslycolocalizedGFP-LC3autophagosomesknockedindicatingelevatedlikelyrelatedinducesdegradationimpairslow-densityVLDLassemblyvalidateactsbindingmediatesregulationcellimportantlyattenuatehighfatdietinducedNAFLDconclusionstudyrevealspotentiallydownstreammTORsignalingpathwayregulatorynetworkhepaticmetabolismcooperationmayprovidenewtargetdisorderLncRP11-675F6respondsreducesviahepatocyteslncRP11-675F6triglycerides

Similar Articles

Cited By